Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy

View through CrossRef
Abstract Background COVID-19 vaccine hesistancy is a serious policy issue in Germany as vaccinations have stagnated at low levels compared to most other European countries. In this context, we study whether and how health workers can be leveraged to promote the COVID-19 vaccination campaign. Methods We employed an information experiment with health workers in Germany to quantify how access to information related to (i) AstraZeneca’s vaccine safety, (ii) misinformation, (iii) individual health risks, and (iv) public health risks can sway health workers’ recommendations for any of the following vaccines: AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech, Sinopharm, and Sputnik-V. The information experiment was conducted as a randomized controlled trial with four treatment arms and was embedded in an online survey. Results Health workers reduce their willingness to recommend four out of six vaccines once they learn about different statements of European and German health authorities with respect to the safety of the AstraZeneca vaccine. Consistent with the discussion on AstraZeneca’s safety focusing on possible side effects among younger women, we find that especially female health workers become less likely to recommend the majority of COVID-19 vaccines. Lastly, we show that health workers vaccine recommendations are not affected by misinformation and appeals to individual or public health. Conclusion In order to mobilize health workers in the fight against vaccine hesitancy, information campaigns need to be tailor-made for the target audience. In particular, health workers react to different types of information than the general public. As with the general public, we provide suggestive evidence that health workers require unambigious messages from drug authorities in order to support vaccination efforts. We believe that a more coordinated and coherent approach of public authorities can reduce the amount of mixed signals that health workers receive and therefore contribute to health workers engagement in the outroll of mass COVID-19 vaccination campaigns. Trial registration The trial was registered retrospectively with the repository of the Open Science Framework (OSF) under the number osf.io/qa4n2.
Title: How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy
Description:
Abstract Background COVID-19 vaccine hesistancy is a serious policy issue in Germany as vaccinations have stagnated at low levels compared to most other European countries.
In this context, we study whether and how health workers can be leveraged to promote the COVID-19 vaccination campaign.
Methods We employed an information experiment with health workers in Germany to quantify how access to information related to (i) AstraZeneca’s vaccine safety, (ii) misinformation, (iii) individual health risks, and (iv) public health risks can sway health workers’ recommendations for any of the following vaccines: AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech, Sinopharm, and Sputnik-V.
The information experiment was conducted as a randomized controlled trial with four treatment arms and was embedded in an online survey.
Results Health workers reduce their willingness to recommend four out of six vaccines once they learn about different statements of European and German health authorities with respect to the safety of the AstraZeneca vaccine.
Consistent with the discussion on AstraZeneca’s safety focusing on possible side effects among younger women, we find that especially female health workers become less likely to recommend the majority of COVID-19 vaccines.
Lastly, we show that health workers vaccine recommendations are not affected by misinformation and appeals to individual or public health.
Conclusion In order to mobilize health workers in the fight against vaccine hesitancy, information campaigns need to be tailor-made for the target audience.
In particular, health workers react to different types of information than the general public.
As with the general public, we provide suggestive evidence that health workers require unambigious messages from drug authorities in order to support vaccination efforts.
We believe that a more coordinated and coherent approach of public authorities can reduce the amount of mixed signals that health workers receive and therefore contribute to health workers engagement in the outroll of mass COVID-19 vaccination campaigns.
Trial registration The trial was registered retrospectively with the repository of the Open Science Framework (OSF) under the number osf.
io/qa4n2.

Related Results

Changes in COVID-19 vaccine hesitancy at different times among residents in Guangzhou, China
Changes in COVID-19 vaccine hesitancy at different times among residents in Guangzhou, China
BackgroundVaccination as a fundamental pillar of promoting public health and interest is critical to limiting the COVID-19 pandemic. However, many citizens are still hesitant about...
Towards a More Critical Public Health Understanding of Vaccine Hesitancy: Key Insights from a Decade of Research
Towards a More Critical Public Health Understanding of Vaccine Hesitancy: Key Insights from a Decade of Research
Vaccine hesitancy has gained renewed attention as an important public health concern worldwide. Against this backdrop, over the last decade, we have conducted various qualitative, ...
Using the Social–Ecological Model to Assess Vaccine Hesitancy and Refusal in a Highly Religious Lower–Middle-Income Country
Using the Social–Ecological Model to Assess Vaccine Hesitancy and Refusal in a Highly Religious Lower–Middle-Income Country
(1) Background: The aim of this study was to understand the factors associated with vaccine hesitancy and refusal in Indonesia using the Social–Ecological Model (SEM). (2) Methods:...
COVID-19 vaccine hesitancy among Tunisian cancer patients in the Salah Azaeiz Institute of Cancer
COVID-19 vaccine hesitancy among Tunisian cancer patients in the Salah Azaeiz Institute of Cancer
Abstract Background Vaccination against SARS-CoV-2 is the most effective way to stop the pandemic and to avoid its related death...
COVID-19 vaccine hesitancy among adults in Hawassa City Administration, Sidama Region, Ethiopia: A community-based study
COVID-19 vaccine hesitancy among adults in Hawassa City Administration, Sidama Region, Ethiopia: A community-based study
ObjectiveThe COVID-19 vaccine is one of the key measures to control the disease. However, some people are hesitant to take the vaccine. The objective of this study was to assess CO...
Vaccine Hesitancy during the Coronavirus Pandemic in South Tyrol, Italy: Linguistic Correlates in a Representative Cross-Sectional Survey
Vaccine Hesitancy during the Coronavirus Pandemic in South Tyrol, Italy: Linguistic Correlates in a Representative Cross-Sectional Survey
Background: German is a minority language in Italy and is spoken by the majority of the inhabitants of the Autonomous Province of Bolzano, South Tyrol. Linguistic group membership ...
The evolution of COVID-19 vaccine hesitancy in Sub-Saharan Africa: evidence from panel survey data
The evolution of COVID-19 vaccine hesitancy in Sub-Saharan Africa: evidence from panel survey data
Abstract Background COVID-19 vaccination efforts are lagging in Sub-Saharan Africa, as just over 20 percent of the population has been fully vaccina...
COVID-19 Vaccine Acceptance in a Sample From the United Arab Emirates General Adult Population: A Cross-Sectional Survey, 2020
COVID-19 Vaccine Acceptance in a Sample From the United Arab Emirates General Adult Population: A Cross-Sectional Survey, 2020
Introduction: The COVID-19 pandemic has placed a tremendous stress on economies and healthcare systems worldwide. Having a vaccine is one of the promising solutions. However, vacci...

Back to Top